Su-Fen Pu

Su-Fen Pu is an experienced medical professional with a robust background in safety surveillance and pharmacovigilance within the pharmaceutical industry. Su-Fen Pu began a career at Sanofi from November 2000 to July 2008, serving in multiple roles including Senior Research Investigator and Case Medical Evaluation Physician. Afterward, Su-Fen Pu held positions at Merck from December 2017 to March 2020, culminating in the role of Director for Global Clinical Safety and Pharmacovigilance. Su-Fen Pu then transitioned to Hutchison MediPharma as Executive Director of Global Patient Safety and Pharmacovigilance, before taking on the position of Senior Medical Director and Global Safety Leader for Oncology Benefit Risk Management at Bayer in November 2020, a role that continues to the present. Prior experience includes a tenure as Director of Safety Surveillance Physician at The Janssen Pharmaceutical Companies of Johnson & Johnson from December 2016 to December 2017.